ADX48621

· Addex Pharma S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADX48621, covering 2012-07-16 to 2012-07-16. Get the full timeline:

Most recent: Clinical Trial Update: ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease [Phase 2]